Key result
Anticoagulation therapy for venous thromboembolism should be administered for at least 3 months, as shorter courses double the recurrence rates.
Answers are grounded in this paper and cite their sources.
Standard therapy for DVT and nonmassive PE requires at least 3 months of anticoagulation, with emerging roles for new oral anticoagulants and risk stratification models to guide therapy duration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eichinger et al. (2012) conducted a review in Venous Thromboembolism. Anticoagulation therapy was evaluated. Anticoagulation therapy for venous thromboembolism should be administered for at least 3 months, as shorter courses double the recurrence rates.
Synapse has enriched 10 related papers. Consider them for comparative context: